Market Report

Protein Contract Manufacturing Market Report 2026-2036

The global Protein Contract Manufacturing market is projected to grow at a CAGR of 9.7% by 2036

SKU: PHA1397 Category: Code: PHA1397Pages: 358
Clear
← Back to category Contract Services

Description

Visiongain has published a new report, Protein Contract Manufacturing Market Report 2026-2036. The global protein contract manufacturing market is valued at US$13.31bn in 2026 and is forecast to reach US$33.62bn by 2036, at a CAGR of 9.7% over the forecast period.

This report provides a comprehensive analysis of the market including market size, growth drivers, competitive positioning, and revenue forecasts across scale of operation, service, expression system, protein type, therapeutic area, and end-user segments.

Access a Free Sample of This Report

Download a sample to explore:

  • Market forecasts and segment breakdowns
  • Competitive and company-level insights
  • Key trends shaping the market
  • Trade, policy, and supply chain analysis

 

Increasing Outsourcing of Protein Biologics Development and Manufacturing

Pharmaceutical and biotechnology companies are increasingly outsourcing protein development and manufacturing to reduce capital requirements, access specialised expertise and accommodate changing production needs. Establishing an internal biologics facility requires substantial investment, experienced personnel, validated processes and continuing regulatory compliance. CDMOs provide access to mammalian and microbial production capabilities across clinical and commercial scales, allowing developers to advance programmes without constructing dedicated facilities.

Lonza has reported that CDMO capacity continues to outpace capacity in customer-owned facilities, as both large and small biopharmaceutical companies increasingly rely on external manufacturing partners. Outsourcing is particularly important for emerging biotechnology companies without commercial infrastructure and established pharmaceutical companies seeking additional capacity, regional production and supply flexibility. The model also enables sponsors to complement internal manufacturing networks rather than replacing them completely. Protein manufacturing outsourcing is increasingly becoming a long-term operating strategy rather than solely a temporary response to capacity shortages.

Report Scope and Data Coverage

  • Global protein contract manufacturing market analysis
  • Revenue forecasts to 2036 with annual growth estimates
  • Segment-level modelling across six segmentation frameworks
  • Regional and national market forecasts across five regions and 14 leading national markets
  • Competitive intelligence on 17 leading companies

Includes both quantitative forecasting and qualitative strategic analysis covering technology, competition, trade dynamics, and supply chain developments.

Our 350-page report provides 136 tables and 197 charts/graphs.

CTA

Segmentation Framework

By Scale of Operation

  • Preclinical / Clinical
  • Commercial

By Service

  • Protein Drug Substance Manufacturing
  • Protein Drug Product Manufacturing
  • Development and Analytical Services

By Expression System

  • Mammalian
  • Microbial
  • Others

By Protein Type

  • Monoclonal Antibodies and Antibody Fragments
  • Fusion Proteins
  • Enzymes
  • Hormones and Growth Factors
  • Cytokines and Interferons
  • Others

By Therapeutic Area

  • Oncology
  • Autoimmune and Inflammatory Disorders
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Therapeutic Areas

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Biosimilar Manufacturers
  • Academic and Research Institutions

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of MEA

Company Intelligence Coverage

This report includes detailed profiles of 17 leading companies, including:

  • Abzena
  • 3P BIOVIAN
  • AGC Biologics
  • Boehringer Ingelheim BioXcellence
  • Curia Global, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza Group AG
  • Catalent, Inc. (Novo Holdings)
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics Co., Ltd.
  • Syngene International Limited
  • Thermo Fisher Scientific Inc. (Patheon Pharma Services)
  • Wacker Biotech GmbH
  • WuXi Biologics

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Technology roadmap and programme wins
  • Strategic outlook

Key Questions Answered

  • How is the protein contract manufacturing market evolving?
  • What is driving and restraining the protein contract manufacturing market?
  • How will each submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2036?
  • How will the market shares for each submarket develop from 2026 to 2036?
  • Will leading protein contract manufacturing markets broadly follow macroeconomic dynamics, or will individual national markets outperform others?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2026 and 2036?

Bespoke Intelligence and Customisation

Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements. This includes:

  • Custom market segmentation and forecasts
  • Competitive benchmarking and strategy analysis
  • Supply chain and sourcing intelligence
  • Biosimilar manufacturing capability assessment
  • Scenario modelling including tariffs and geopolitical risk

Speak to our team about bespoke requirements

Why This Market Intelligence Matters

The protein contract manufacturing landscape is undergoing sustained expansion driven by pipeline growth in biologics and biosimilars, increasing outsourcing by both emerging biotechnology companies and established pharmaceutical firms, and significant CDMO investment in scalable, geographically distributed manufacturing capacity.

CDMOs that offer integrated development-to-commercial services, regional manufacturing presence, and proven large-scale mammalian cell-culture capability are best positioned to capture durable programme value over the next decade.

Purchase the Protein Contract Manufacturing Market Report 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Access the Full Forecast and Competitive Analysis

Purchase the Protein Contract Manufacturing Market Report 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Download sample or contact us for enterprise access

 

For enterprise licensing, customised segmentation or analyst briefings, contact Visiongain directly at contactus@visiongain.com

Government Registration
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Protein Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include
1.6 Who is This Report For
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Impact Analysis
3.3 Market Driving Factors
3.4 Market Restraining Factors
3.5 Market Opportunities
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitutes
3.6.5 Threat of New Entrants
3.7 PEST Analysis

4 U.S. Tariffs: What’s the Impact on Global Protein Contract Manufacturing Market?
4.1 Overview
4.2 V-Shaped Recovery Scenario
4.2.1 Why V-Shaped Recovery?
4.2.2 Impact from Tariffs
4.2.3 Market Dynamics and Demand Recovery
4.2.4 Policy and Funding Support
4.2.5 Timeframe for Recovery
4.3 U-Shaped Recovery Scenario
4.3.1 Why U-Shaped Recovery?
4.3.2 Impact from Tariffs
4.3.3 Market Dynamics and Demand Recovery
4.3.4 Policy and Funding Support
4.3.5 Timeframe for Recovery
4.4 L-Shaped Recovery Scenario
4.4.1 Why L-Shaped Recovery?
4.4.2 Impact from Tariffs
4.4.3 Market Dynamics and Demand Recovery
4.4.4 Policy and Funding Support
4.4.5 Timeframe for Recovery
4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2026-2031) and Long-term (2026-2036) Planning?
4.6 Impact of U.S. and China Trade War on Protein Contract Manufacturing Market
4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?

5 Protein Contract Manufacturing Market Analysis by Scale of Operation
5.1 Key Findings
5.2 Scale of Operation Segment: Market Attractiveness Index
5.3 Preclinical / Clinical
5.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.3.2 Market Share by Region, 2026 & 2036 (%)
5.4 Commercial
5.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2026 & 2036 (%)

6 Protein Contract Manufacturing Market Analysis by Service
6.1 Key Findings
6.2 Service Segment: Market Attractiveness Index
6.3 Protein Drug Substance Manufacturing
6.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.3.2 Market Share by Region, 2026 & 2036 (%)
6.4 Protein Drug Product Manufacturing
6.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Development and Analytical Services
6.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2026 & 2036 (%)

7 Protein Contract Manufacturing Market Analysis by Expression System
7.1 Key Findings
7.2 Expression System Segment: Market Attractiveness Index
7.3 Mammalian
7.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.3.2 Market Share by Region, 2026 & 2036 (%)
7.4 Microbial
7.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Others
7.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2026 & 2036 (%)

8 Protein Contract Manufacturing Market Analysis by Protein Type
8.1 Key Findings
8.2 Protein Type Segment: Market Attractiveness Index
8.3 Monoclonal Antibodies and Antibody Fragments
8.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.3.2 Market Share by Region, 2026 & 2036 (%)
8.4 Fusion Proteins
8.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.4.2 Market Share by Region, 2026 & 2036 (%)
8.5 Enzymes
8.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.5.2 Market Share by Region, 2026 & 2036 (%)
8.6 Hormones and Growth Factors
8.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.6.2 Market Share by Region, 2026 & 2036 (%)
8.7 Cytokines and Interferons
8.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.7.2 Market Share by Region, 2026 & 2036 (%)
8.8 Others
8.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.8.2 Market Share by Region, 2026 & 2036 (%)

9 Protein Contract Manufacturing Market Analysis by Therapeutic Area
9.1 Key Findings
9.2 Therapeutic Area Segment: Market Attractiveness Index
9.3 Oncology
9.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.3.2 Market Share by Region, 2026 & 2036 (%)
9.4 Autoimmune and Inflammatory Disorders
9.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.4.2 Market Share by Region, 2026 & 2036 (%)
9.5 Metabolic Diseases
9.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.5.2 Market Share by Region, 2026 & 2036 (%)
9.6 Cardiovascular Diseases
9.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.6.2 Market Share by Region, 2026 & 2036 (%)
9.7 Infectious Diseases
9.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.7.2 Market Share by Region, 2026 & 2036 (%)
9.8 Other Therapeutic Area
9.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.8.2 Market Share by Region, 2026 & 2036 (%)

10 Protein Contract Manufacturing Market Analysis by End-Users
10.1 Key Findings
10.2 End-users Segment: Market Attractiveness Index
10.3 Pharmaceutical Companies
10.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
10.3.2 Market Share by Region, 2026 & 2036 (%)
10.4 Biotechnology Companies
10.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
10.4.2 Market Share by Region, 2026 & 2036 (%)
10.5 Biosimilar Manufacturers
10.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
10.5.2 Market Share by Region, 2026 & 2036 (%)
10.6 Academic and Research Institutions
10.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
10.6.2 Market Share by Region, 2026 & 2036 (%)

11 Protein Contract Manufacturing Market Analysis by Region
11.1 Key Findings
11.2 Regional Market Size Estimation and Forecast

12 North America Protein Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 North America Protein Contract Manufacturing Market Attractiveness Index
12.3 North America Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
12.4 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
12.6 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Service
12.7 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
12.8 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
12.9 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
12.10 North America Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
12.11 U.S. Protein Contract Manufacturing Market Analysis
12.12 Canada Protein Contract Manufacturing Market Analysis

13 Europe Protein Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 Europe Protein Contract Manufacturing Market Attractiveness Index
13.3 Europe Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
13.4 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Country
13.5 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
13.6 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Service
13.7 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
13.8 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
13.9 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
13.10 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
13.11 Germany Protein Contract Manufacturing Market Analysis
13.12 UK Protein Contract Manufacturing Market Analysis
13.13 France Protein Contract Manufacturing Market Analysis
13.14 Italy Protein Contract Manufacturing Market Analysis
13.15 Rest of Europe Protein Contract Manufacturing Market Analysis

14 Asia Pacific Protein Contract Manufacturing Market Analysis
14.1 Key Findings
14.2 Asia Pacific Protein Contract Manufacturing Market Attractiveness Index
14.3 Asia Pacific Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
14.4 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Country
14.5 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
14.6 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Service
14.7 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
14.8 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
14.9 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
14.10 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
14.11 Japan Protein Contract Manufacturing Market Analysis
14.12 China Protein Contract Manufacturing Market Analysis
14.13 India Protein Contract Manufacturing Market Analysis
14.14 Australia Protein Contract Manufacturing Market Analysis
14.15 Rest of Asia Pacific Protein Contract Manufacturing Market Analysis

15 Latin America Protein Contract Manufacturing Market Analysis
15.1 Key Findings
15.2 Latin America Protein Contract Manufacturing Market Attractiveness Index
15.3 Latin America Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
15.4 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Country
15.5 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
15.6 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Service
15.7 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
15.8 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
15.9 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
15.10 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
15.11 Brazil Protein Contract Manufacturing Market Analysis
15.12 Mexico Protein Contract Manufacturing Market Analysis
15.13 Rest of Latin America Protein Contract Manufacturing Market Analysis

16 MEA Protein Contract Manufacturing Market Analysis
16.1 Key Findings
16.2 MEA Protein Contract Manufacturing Market Attractiveness Index
16.3 MEA Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
16.4 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Country
16.5 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
16.6 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Service
16.7 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
16.8 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
16.9 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
16.10 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
16.11 GCC Protein Contract Manufacturing Market Analysis
16.12 South Africa Protein Contract Manufacturing Market Analysis
16.13 Rest of MEA Protein Contract Manufacturing Market Analysis

17 Company Profiles
17.1 Abzena
17.1.1 Company Snapshot
17.1.2 Company Overview
17.1.3 Company Financials
17.1.3.1 Revenue, 2022-2025 (US$ Million)
17.1.3.2 R&D, 2022-2025 (US$ Million)
17.1.4 Business Segment Market Shares (%), 2025
17.1.5 Geographic Segment Market Shares (%), 2025
17.1.6 Service Benchmarking
17.1.7 Strategic Outlook
17.2 3P BIOVIAN
17.2.1 Company Snapshot
17.2.2 Company Overview
17.2.3 Company Financials
17.2.3.1 Revenue, 2022-2025 (US$ Million)
17.2.3.2 R&D, 2022-2025 (US$ Million)
17.2.4 Business Segment Market Shares (%), 2025
17.2.5 Geographic Segment Market Shares (%), 2025
17.2.6 Service Benchmarking
17.2.7 Strategic Outlook
17.3 AGC Biologics
17.3.1 Company Snapshot
17.3.2 Company Overview
17.3.3 Company Financials
17.3.3.1 Revenue, 2022-2025 (US$ Million)
17.3.3.2 R&D, 2022-2025 (US$ Million)
17.3.4 Business Segment Market Shares (%), 2025
17.3.5 Geographic Segment Market Shares (%), 2025
17.3.6 Service Benchmarking
17.3.7 Strategic Outlook
17.4 Boehringer Ingelheim BioXcellence
17.4.1 Company Snapshot
17.4.2 Company Overview
17.4.3 Company Financials
17.4.3.1 Revenue, 2022-2025 (US$ Million)
17.4.3.2 R&D, 2022-2025 (US$ Million)
17.4.4 Business Segment Market Shares (%), 2025
17.4.5 Geographic Segment Market Shares (%), 2025
17.4.6 Service Benchmarking
17.4.7 Strategic Outlook
17.5 Curia Global, Inc.
17.5.1 Company Snapshot
17.5.2 Company Overview
17.5.3 Company Financials
17.5.3.1 Revenue, 2022-2025 (US$ Million)
17.5.3.2 R&D, 2022-2025 (US$ Million)
17.5.4 Business Segment Market Shares (%), 2025
17.5.5 Geographic Segment Market Shares (%), 2025
17.5.6 Service Benchmarking
17.5.7 Strategic Outlook
17.6 Cytovance Biologics
17.6.1 Company Snapshot
17.6.2 Company Overview
17.6.3 Company Financials
17.6.3.1 Revenue, 2022-2025 (US$ Million)
17.6.3.2 R&D, 2022-2025 (US$ Million)
17.6.4 Business Segment Market Shares (%), 2025
17.6.5 Geographic Segment Market Shares (%), 2025
17.6.6 Service Benchmarking
17.6.7 Strategic Outlook
17.7 FUJIFILM Diosynth Biotechnologies
17.7.1 Company Snapshot
17.7.2 Company Overview
17.7.3 Company Financials
17.7.3.1 Revenue, 2022-2025 (US$ Million)
17.7.3.2 R&D, 2022-2025 (US$ Million)
17.7.4 Business Segment Market Shares (%), 2025
17.7.5 Geographic Segment Market Shares (%), 2025
17.7.6 Service Benchmarking
17.7.7 Strategic Outlook
17.8 KBI Biopharma
17.8.1 Company Snapshot
17.8.2 Company Overview
17.8.3 Company Financials
17.8.3.1 Revenue, 2022-2025 (US$ Million)
17.8.3.2 R&D, 2022-2025 (US$ Million)
17.8.4 Business Segment Market Shares (%), 2025
17.8.5 Geographic Segment Market Shares (%), 2025
17.8.6 Service Benchmarking
17.8.7 Strategic Outlook
17.9 Lonza Group AG
17.9.1 Company Snapshot
17.9.2 Company Overview
17.9.3 Company Financials
17.9.3.1 Revenue, 2022-2025 (US$ Million)
17.9.3.2 R&D, 2022-2025 (US$ Million)
17.9.4 Business Segment Market Shares (%), 2025
17.9.5 Geographic Segment Market Shares (%), 2025
17.9.6 Service Benchmarking
17.9.7 Strategic Outlook
17.10 Catalent, Inc. (Novo Holdings)
17.10.1 Company Snapshot
17.10.2 Company Overview
17.10.3 Company Financials
17.10.3.1 Revenue, 2022-2025 (US$ Million)
17.10.3.2 R&D, 2022-2025 (US$ Million)
17.10.4 Business Segment Market Shares (%), 2025
17.10.5 Geographic Segment Market Shares (%), 2025
17.10.6 Service Benchmarking
17.10.7 Strategic Outlook
17.11 ProBioGen AG
17.11.1 Company Snapshot
17.11.2 Company Overview
17.11.3 Company Financials
17.11.3.1 Revenue, 2022-2025 (US$ Million)
17.11.3.2 R&D, 2022-2025 (US$ Million)
17.11.4 Business Segment Market Shares (%), 2025
17.11.5 Geographic Segment Market Shares (%), 2025
17.11.6 Service Benchmarking
17.11.7 Strategic Outlook
17.12 Rentschler Biopharma SE
17.12.1 Company Snapshot
17.12.2 Company Overview
17.12.3 Company Financials
17.12.3.1 Revenue, 2022-2025 (US$ Million)
17.12.3.2 R&D, 2022-2025 (US$ Million)
17.12.4 Business Segment Market Shares (%), 2025
17.12.5 Geographic Segment Market Shares (%), 2025
17.12.6 Service Benchmarking
17.12.7 Strategic Outlook
17.13 Samsung Biologics Co., Ltd.
17.13.1 Company Snapshot
17.13.2 Company Overview
17.13.3 Company Financials
17.13.3.1 Revenue, 2022-2025 (US$ Million)
17.13.3.2 R&D, 2022-2025 (US$ Million)
17.13.4 Business Segment Market Shares (%), 2025
17.13.5 Geographic Segment Market Shares (%), 2025
17.13.6 Service Benchmarking
17.13.7 Strategic Outlook
17.14 Syngene International Limited
17.14.1 Company Snapshot
17.14.2 Company Overview
17.14.3 Company Financials
17.14.3.1 Revenue, 2022-2025 (US$ Million)
17.14.3.2 R&D, 2022-2025 (US$ Million)
17.14.4 Business Segment Market Shares (%), 2025
17.14.5 Geographic Segment Market Shares (%), 2025
17.14.6 Service Benchmarking
17.14.7 Strategic Outlook
17.15 Thermo Fisher Scientific Inc. (Patheon Pharma Services)
17.15.1 Company Snapshot
17.15.2 Company Overview
17.15.3 Company Financials
17.15.3.1 Revenue, 2022-2025 (US$ Million)
17.15.3.2 R&D, 2022-2025 (US$ Million)
17.15.4 Business Segment Market Shares (%), 2025
17.15.5 Geographic Segment Market Shares (%), 2025
17.15.6 Service Benchmarking
17.15.7 Strategic Outlook
17.16 Wacker Biotech GmbH
17.16.1 Company Snapshot
17.16.2 Company Overview
17.16.3 Company Financials
17.16.3.1 Revenue, 2022-2025 (US$ Million)
17.16.3.2 R&D, 2022-2025 (US$ Million)
17.16.4 Business Segment Market Shares (%), 2025
17.16.5 Geographic Segment Market Shares (%), 2025
17.16.6 Service Benchmarking
17.16.7 Strategic Outlook
17.17 WuXi Biologics
17.17.1 Company Snapshot
17.17.2 Company Overview
17.17.3 Company Financials
17.17.3.1 Revenue, 2022-2025 (US$ Million)
17.17.3.2 R&D, 2022-2025 (US$ Million)
17.17.4 Business Segment Market Shares (%), 2025
17.17.5 Geographic Segment Market Shares (%), 2025
17.17.6 Service Benchmarking
17.17.7 Strategic Outlook

18 Conclusion and Recommendations
18.1 Concluding Remarks from Visiongain
18.2 Recommendations for Market Players

List of Companies Profiled in the Report
Abzena
3P BIOVIAN
AGC Biologics
Boehringer Ingelheim BioXcellence
Curia Global, Inc.
Cytovance Biologics
FUJIFILM Diosynth Biotechnologies
KBI Biopharma
Lonza Group AG
Catalent, Inc. (Novo Holdings)
ProBioGen AG
Rentschler Biopharma SE
Samsung Biologics Co., Ltd.
Syngene International Limited
Thermo Fisher Scientific Inc. (Patheon Pharma Services)
Wacker Biotech GmbH
WuXi Biologics

List of Other Companies Mentioned in the Report
Ajinomoto Bio-Pharma Services
Avid Bioservices, Inc.
Batavia Biosciences B.V.
Bora Biologics Co., Ltd.
JOINN Biologics US Inc.
Just–Evotec Biologics
Kemwell Biopharma Pvt. Ltd.
Northway Biotech
Polpharma Biologics
Richter-Helm BioLogics GmbH & Co. KG

List of Associations Mentioned in the Report
Association for Accessible Medicines (AAM)
Bio-Process Systems Alliance (BPSA)
BioIndustry Association (BIA)
Biotechnology Innovation Organization (BIO)
European Association for Bioindustries (EuropaBio)
European Society for the Advancement of Cell Technology (ESACT)
International Alliance for Biological Standardization (IABS)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
International Society for Pharmaceutical Engineering (ISPE)
Parenteral Drug Association (PDA)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Society for Biological Engineering (SBE)
Society for Industrial Microbiology and Biotechnology (SIMB)